Ambient sensor rooms to spot early problems in hospitalized cancer patients
Official title: Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer
Run by Mayo Clinic · NCT07477886 · Data updated 2026-11-12
This test will try whether special hospital rooms with cameras, microphones, and temperature sensors can help staff spot early delirium, falls, sleep problems, or mood changes in adults hospitalized with cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 134 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | February 10, 2026 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07477886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are English-speaking adults (age ≥18) with a current or prior cancer diagnosis who are admitted to one of the six ambient-equipped rooms at Mayo Clinic Rochester and are not receiving comfort or end-of-life care.
✕Probably not a fit
Patients who are under 18, are incarcerated, are receiving comfort or end-of-life care, or whose primary language is not English are excluded and would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Using an observational design, this study collects continuous ambient data from video, audio, and thermographic sensors installed in six hospital rooms to detect early signs of delirium, falls, sleep disruption, and mood changes in cancer patients. Adult patients admitted to the Eisenberg 4-3 unit at Mayo Clinic Rochester with a current or prior cancer diagnosis are enrolled if they are not receiving end-of-life care and speak English. Clinicians who provide direct care in those rooms are also included to help link sensor signals to clinical events and workflows. The study does not change medical care and instead records environmental and behavioral signals to develop detection methods that could inform future interventions.
Why it matters
Potential benefit: If effective, the sensors could enable earlier detection of clinical problems so clinicians can intervene sooner and reduce harm and recovery time.
How similar studies have gone: Related work using continuous video, audio, and bedside sensors has shown promise for detecting falls and delirium episodes, but large-scale clinical validation remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients: * Age \>= 18 * Not receiving comfort/end-of-life care * Not incarcerated * Admitted to one of the six rooms equipped with ambient technology * History of cancer or has a cancer diagnosis * Clinicians: * Age \>= 18 * Participating in direct patient care activities on Eisenberg units 4-3 as an employee of Mayo Clinic Exclusion Criteria: * Patients: * Age \< 18 years * Receiving comfort or end-of-life care * Incarceration (prisoner status) * Primary language is not English * Clinicians: * Age \< 18 years
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Allyson K Palmer, MD, PhD — Mayo Clinic
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if virtual informed consent methods help people decide to join cancer research
This trial tests whether virtual human communicators and different consent messages can influence cancer patients’ understanding and willingness to participate in research.
-
AI-powered supportive care chatbot for young adult cancer survivors
A chatbot driven by artificial intelligence is tested to help young adult cancer survivors manage symptoms and care needs after treatment.
-
Telehealth pharmacist-led opioid education for cancer patients
This pilot tests a telehealth group education session led by a palliative care pharmacist to help adults with cancer use opioids more safely and effectively.
-
Mindfulness program to help with symptoms in chronic graft-versus-host disease
A mindfulness-based program is being tested to see if it can reduce patient-reported symptoms for adults with chronic graft-versus-host disease after a stem cell transplant.
-
Non-invasive brain stimulation to help chemotherapy-induced nerve problems in cancer survivors
This trial tests whether a gentle brain stimulation method (tDCS) can help reduce numbness, tingling, and pain from CIPN in cancer survivors who are not currently in treatment.
-
Voices: sharing messages of wisdom and hope during illness
This project will see if recording semi-structured interviews with adult cancer patients (and optional caregivers) affects patients' sense of dignity and caregiver support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.